What is Butterfly Network Inc?
develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.
BFLY · Verdict
Moderate reward · elevated risk
BFLY's standout is balance sheet; volatility and cash flow weigh on the picture.
Based on 88% data coverage
BFLY · Verdict
Current ratio 3.83
Weak vs peers
-16% free-cash-flow margin
-79% net margin · -42% ROE
Model-based scoring. For information only — not financial advice.
develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 1.29B.
The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.